4/1
07:41 am
cntx
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers [Yahoo! Finance]
Medium
Report
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers [Yahoo! Finance]
4/1
07:30 am
cntx
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
Medium
Report
Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
3/27
09:19 am
cntx
Companies Like Context Therapeutics (NASDAQ:CNTX) Could Be Quite Risky [Yahoo! Finance]
Medium
Report
Companies Like Context Therapeutics (NASDAQ:CNTX) Could Be Quite Risky [Yahoo! Finance]
3/21
12:34 pm
cntx
Context Therapeutics Inc. (NASDAQ: CNTX) had its price target lowered by analysts at HC Wainwright from $5.00 to $4.00. They now have a "buy" rating on the stock.
Medium
Report
Context Therapeutics Inc. (NASDAQ: CNTX) had its price target lowered by analysts at HC Wainwright from $5.00 to $4.00. They now have a "buy" rating on the stock.
3/21
07:51 am
cntx
Context Therapeutics Reports Full Year 2023 Operating and Financial Results [Yahoo! Finance]
Medium
Report
Context Therapeutics Reports Full Year 2023 Operating and Financial Results [Yahoo! Finance]
3/21
07:43 am
cntx
Context Therapeutics Reports Full Year 2023 Operating and Financial Results
Medium
Report
Context Therapeutics Reports Full Year 2023 Operating and Financial Results